OncoSec Medical Inc (ONCSQ)

[TTTPKL]

There are several issues I point out in my previous posts. For example, they have mentioned about the interim data on Merkel cell lymphoma, I still don't know exactly how many patients are in the trials and if they are still accruing patients. In addition, how about the cutaneous T cell lymphoma. I remember several months ago they still have problems finding patients and they switch to a well known oncology in Stanford to conduct the trial. I have not heard from the company about any update. In regard to the combo trial, I heard they mentioned it several time. I have yet to hear from them when they submit the combo trial application or have they met with the FDA. They have not said a word about that (or may be I miss it).
The data presented in ESMO about the convincing data to support the conversion of non-responder to responder, I don't think it is that convincing. Don't get me wrong I really want ONCS to succeed (I have over 200k shares). However, I am getting nervous. At least one positive sign is that they are hiring several people.